Skip to main content
Caplight Logo









Cellbyte

Cellbyte

Private
MunichHealthcare & Life Scienceshttps://www.cellbyte.com/

Last Round

Seed

Nov 18, 2025

Total Funding Raised

$3.25M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Cellbyte is a pharmaceutical technology company that provides an AI-driven platform to automate pricing, market access, and regulatory workflows for drug launches.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Vertical SaaS, Workflow Automation, Business Intelligence, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

pricing and market accessP&MApharma analyticsvertical SaaSdocument intelligencehealth technology assessmentHTAdrug launch softwareAI copilotworkflow automationpharma commercializationRAGretrieval-augmented generationpharma techAI agentdata vault

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellbyte Comparables

Compare Cellbyte with similar companies based on industry and business-model similarity.

Cellbyte comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cohere
89%
TRiBECA Knowledge
78%
Sleuth Insights
76%

Cellbyte Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2025
AcceleratorApr 3, 2024

Key People

Founding team and executive leadership

Samuel M.

Co-founder & CTO

Founding Team

Daniel Moreira

Co-founder & Co-CEO

Founding Team

Cellbyte Investors

Notable investors and investment history

Cellbyte investors
InvestorRounds
Saras CapitalSeed
Pace VenturesSeed
Y CombinatorAccelerator, Seed
Springboard Health AngelsSeed
Frontline VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 110% MoM, reaching 1.2K.

  • Jun 19, 2026

    Job posting indicates double-digit month-over-month growth.

Cellbyte Filings

Explore SEC and related filing metadata, where available.

Cellbyte filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellbyte's valuation, stock price, and market status.

Is Cellbyte a public or private company?

Cellbyte is a private company.

What is the current stock price of Cellbyte?

Cellbyte is a private company with no public stock price. No recent secondary market data is available.

How much is Cellbyte worth (valuation)?

Valuation information for Cellbyte is not publicly available.

Can I buy Cellbyte stock?

Cellbyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellbyte's last funding round?

Cellbyte's most recent funding round was Seed on November 18, 2025.

Who are the main investors in Cellbyte?

Key investors in Cellbyte include Frontline Ventures.

Will Cellbyte IPO soon?

No public IPO plans have been announced for Cellbyte.

How can I track Cellbyte secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellbyte's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Employee Range11
Year Founded2024
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?